PD-L1 expression is assessed using one of three scoring systems: Tumour Proportion Score (TPS), Combined Positive Score (CPS) or Immune Cell (IC) score, with each system requiring specific spatial context and cell classification [97]. This evidence concerns the gene CD274 and neoplasm.